Protagenic Therapeutics Inc
NASDAQ:PTIX
Protagenic Therapeutics Inc Stock, NASDAQ:PTIX
149 Fifth Avenue, Suite 500, New York, New York 10010
United States of America
Phone: +1.212.994.8200
Number of Employees: 3
Description
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.